X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (1) 1
aged (1) 1
aged, 80 and over (1) 1
antibody-drug conjugate (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
bendamustine hydrochloride - administration & dosage (1) 1
brentuximab vedotin (1) 1
cd30 (1) 1
cyclophosphamide (1) 1
cyclophosphamide - administration & dosage (1) 1
diagnosis (1) 1
disease (1) 1
efficacy (1) 1
experience (1) 1
female (1) 1
fludarabine (1) 1
hematology (1) 1
hematology, oncology and palliative medicine (1) 1
high-dose chemoradiotherapy (1) 1
hodgkin lymphoma (1) 1
humans (1) 1
immunotherapy (1) 1
index medicus (1) 1
initial therapy (1) 1
leukemia, lymphocytic, chronic, b-cell - drug therapy (1) 1
leukemia, lymphocytic, chronic, b-cell - pathology (1) 1
leukemia, lymphocytic, chronic, b-cell - physiopathology (1) 1
lymphoma (1) 1
male (1) 1
middle aged (1) 1
minimal residual disease (1) 1
neoplasm staging (1) 1
ofatumumab (1) 1
oncology (1) 1
open-label (1) 1
pembrolizumab (1) 1
phase-3 (1) 1
phase-ii (1) 1
registries (1) 1
remission induction (1) 1
research paper (1) 1
risk (1) 1
rituximab - administration & dosage (1) 1
safety (1) 1
stem cell transplantation (1) 1
stem-cell transplantation (1) 1
survival (1) 1
survival rate (1) 1
vidarabine - administration & dosage (1) 1
vidarabine - analogs & derivatives (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 7, pp. e317 - e329
Journal Article
JOURNAL OF CANCER, ISSN 1837-9664, 2019, Volume 10, Issue 21, pp. 5041 - 5048
Introduction: Clinical trials have demonstrated the effectiveness of the CD30-targeted antibody- drug conjugate brentuximab vedotin (BV) for the treatment of... 
CD30 | EFFICACY | SAFETY | stem cell transplantation | PHASE-II | RISK | registries | brentuximab vedotin | antibody-drug conjugate | PEMBROLIZUMAB | ONCOLOGY | DISEASE | EXPERIENCE | STEM-CELL TRANSPLANTATION | Hodgkin lymphoma | HIGH-DOSE CHEMORADIOTHERAPY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.